Jelena Djuris
Overview
Explore the profile of Jelena Djuris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aleksic I, Glisic T, Cirin-Varadan S, Djuris M, Djuris J, Parojcic J
Pharmaceutics
. 2024 Nov;
16(11).
PMID: 39598596
: Improving the production rates of modern tablet presses places ever greater demands on the performance of excipients. Although co-processing has emerged as a promising solution, there is still a...
2.
Djuris J, Cvijic S, Djekic L
Pharmaceuticals (Basel)
. 2024 Feb;
17(2).
PMID: 38399392
The pharmaceutical industry has faced significant changes in recent years, primarily influenced by regulatory standards, market competition, and the need to accelerate drug development. Model-informed drug development (MIDD) leverages quantitative...
3.
Glisic T, Djuris J, Vasiljevic I, Parojcic J, Aleksic I
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986602
The processing of liquisolid systems (LSS), which are considered a promising approach to improving the oral bioavailability of poorly soluble drugs, has proven challenging due to the relatively high amount...
4.
Medarevic D, Djuris J, Krkobabic M, Ibric S
Pharmaceutics
. 2021 Dec;
13(12).
PMID: 34959447
Co-processing is commonly used approach to improve functional characteristics of pharmaceutical excipients to become suitable for tablet production by direct compression. This study aimed to improve tableting characteristics of lactose...
5.
Kurcubic I, Vajic U, Cvijic S, Crevar-Sakac M, Bogavac-Stanojevic N, Miloradovic Z, et al.
Int J Pharm
. 2021 Nov;
610:121266.
PMID: 34752918
The objective of this study was to formulate extended-release mucoadhesive buccal tablets of propranolol hydrochloride in order to provide a prolonged absorption of propranolol hydrochloride from the buccal mucosa and...
6.
Djuris J, Cirin-Varadjan S, Aleksic I, Djuris M, Cvijic S, Ibric S
Pharmaceutics
. 2021 Jun;
13(5).
PMID: 34063158
Co-processing (CP) provides superior properties to excipients and has become a reliable option to facilitated formulation and manufacturing of variety of solid dosage forms. Development of directly compressible formulations with...
7.
Krivokapic J, Ivanovic J, Djuris J, Medarevic D, Potpara Z, Maksimovic Z, et al.
Saudi Pharm J
. 2020 Jun;
28(6):710-718.
PMID: 32550803
The objective of this work was to study the relation between the manufacturing conditions of microcrystalline cellulose (MCC), its physicochemical properties and its tableting behavior. Two different preparation procedures were...
8.
Madzarevic M, Medarevic D, Vulovic A, Sustersic T, Djuris J, Filipovic N, et al.
Pharmaceutics
. 2019 Oct;
11(10).
PMID: 31635414
The aim of this work was to investigate effects of the formulation factors on tablet printability as well as to optimize and predict extended drug release from cross-linked polymeric ibuprofen...
9.
Medarevic D, Djuris J, Barmpalexis P, Kachrimanis K, Ibric S
Pharmaceutics
. 2019 Aug;
11(8).
PMID: 31374926
The development of stable solid dispersion formulations that maintain desired improvement of drug dissolution rate during the entire shelf life requires the analysis of drug-polymer solubility and miscibility. Only if...
10.
Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapcevic A, Ibric S
Int J Pharm
. 2018 Nov;
554:190-200.
PMID: 30414899
Solid dispersions production is one of the substantial approaches for improvement of poor drug solubility. Additionally, supercritical fluid assisted method for preparation of solid dispersions can offer many advantages in...